|  |  |  | | | | Diseases | |  | Multiple Myeloma Trials |
| | |
| |  | Information Booklet |
A booklet produced by Leukaemia & Lymphoma Research giving background information on clinical trials is available to download.
Text version of the booklet
| Registers of Trials |
Current Controlled Trials
International Cancer Research Portfolio - a register of UK and US cancer research (including trials)
Last updated 24/02/2010
| Leukaemia & Lymphoma Research sponsored trials |
| MERIT (Myeloma Renal Impairment Trial) | | Trial Code: | ISRCTN37161699 | | Type: | Phase III | | Status: | Open | | Website: | http://www.ukmf.org.uk/pdf/merit.pdf | Introduction
MERIT is a new, multicentre, randomised controlled phase III trial, funded by Leukaemia & Lymphoma Research and Cancer Research UK, and is included in the National Cancer Research Network Trials Portfolio.
Primary question
Does the addition of plasma exchange (PE) to chemotherapy increase the likelihood of renal recovery in patients with acute renal failure associated with newly diagnosed myeloma? |
Last updated 24/02/2010
| Non-Leukaemia & Lymphoma Research sponsored trials |
The UK Myeloma Forum (UKMF) maintain a listing of current UK myeloma clinical trials on their website.
Last updated 24/02/2010 |
|
|
|
